Monday, December 19, 2011

Amgen Getting Its Groove Back

Amgen (NASDAQ: AMGN ) This independent biotech company has been a leader in
the development of genetically based research and treatment for cancer, anemia,
rheumatoid arthritis and a host of other major illnesses.

No comments:

Post a Comment

LinkWithin

Related Posts Plugin for WordPress, Blogger...